Knockdown of UHRF1 by lentivirus-mediated shRNA inhibits ovarian cancer cell growth

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 4, 2015, Pages 1343-1348

  Yan, Feng ^a,b   Shao, Li Jia ^b   Hu, Xiao Ya ^a  

^a YANGZHOU UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Ovarian cancer cells; Phosphorylation; Transcription factors; UHRF1

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; TUMOR MARKER; UHRF1 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; LENTIVIRINAE; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BIOMARKERS, TUMOR; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEINS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; LENTIVIRUS; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84926135842     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.4.1343     Document Type: Article

References (12)

1. Abbady AQ, Bronner C, Bathami K, et al (2005). TCR pathway involves ICBP90 gene down-regulation via E2F binding sites. Biochem Pharmacol, 70, 570-9.
2. Achour M, Mousli M, Alhosin M, et al (2013). Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1. Biochem Biophys Res Commun, 430, 208-12.
3. Alhosin M, Sharif T, Mousli M, et al (2011). Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res, 30, 41.
4. Arima Y, Hirota T, Bronner C, et al (2004). Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes to Cells, 9, 131-42.
5. Dandache I, et al (2012). Anti-cancer properties of cranberry juice in human colon cancer: Characterization of the cellular and molecular mechanisms. Fundament Clin Pharmacol, 26, 40.
6. Fang L, Shanqu L, Ping G, et al (2012). Gene therapy with RNAi targeting UHRF1 driven by tumor-specifific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo. Cancer Chemotherapy Pharmacol, 69, 1079-87.
7. Geng Y, Gao Y, Ju H, et al (2012). Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING fifinger domains 1 in breast cancer patients. Cancer Science, 104, 194-9.
8. Jenkins Y, Markovtsov V, Lang W, et al (2005). Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING protein, in tumor cell growth. Molecular Biology of the Cell, 16, 5621-9.
9. Mousli M, Hopfner R, Abbady AQ, et al (2013). ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br J Cancer, 89, 120-7.
10. Tien AL, Senbanerjee S, Kulkarni A, et al (2011). UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis. Biochemical J, 435, 175-85.
11. Wang F, Yang YZ, Shi CZ, et al (2012). UHRF1 promotes cell growth and metastasis through repression of p16 ink4a in colorectal cancer. Ann Surgical Oncol, 19, 2753-62.
12. Yang G.L, Zhang LH, Bo JJ, et al (2012). UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer. Medical Oncol, 29, 842-7.